STERIS plc (NYSE:STE) Shares Acquired by Citizens Financial Group Inc. RI

Citizens Financial Group Inc. RI boosted its holdings in STERIS plc (NYSE:STE) by 5.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 975 shares of the medical equipment provider’s stock after acquiring an additional 54 shares during the period. Citizens Financial Group Inc. RI’s holdings in STERIS were worth $201,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Ashton Thomas Securities LLC acquired a new position in shares of STERIS in the 3rd quarter valued at $25,000. Human Investing LLC acquired a new stake in shares of STERIS during the fourth quarter valued at about $31,000. Anfield Capital Management LLC raised its stake in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 91 shares during the period. Central Pacific Bank Trust Division lifted its holdings in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC boosted its position in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 137 shares during the period. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

STERIS Stock Performance

NYSE STE opened at $227.04 on Friday. The company has a fifty day moving average of $219.17 and a two-hundred day moving average of $222.58. The company has a market capitalization of $22.31 billion, a PE ratio of 48.20 and a beta of 0.92. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be given a $0.57 dividend. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.00%. STERIS’s dividend payout ratio (DPR) is 48.41%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on STE. Piper Sandler increased their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Stephens reissued an “overweight” rating and set a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.